MASH: A Central Player in the Cardiovascular-Kidney-Liver Metabolic Syndrome (R7)
January 1-5, 2028
| Location to be Determined
Bart Staels
Saturday, January 1, 2028
| 4:00–8:00 PM |
Registration |
|
| 6:00–8:00 PM |
Welcome Mixer |
|
| 12:25–1:00 PM |
Poster Setup |
|
| 8:00–8:10 AM |
Welcome Remarks |
|
| 8:10–9:00 AM |
Keynote Address |
|
| |
Arun J. Sanyal †, Virginia Commonwealth University Medical Center
MASH as a Systemic Disease Across the Cardiovascular-Kidney-Metabolic Continuum |
|
| 9:00–11:15 AM |
MASH as a Multisystem Disease - Whole-Patient Clinical Integration and Human Genetics |
|
| |
Alina M. Allen, Mayo Clinic
The Liver in CKLM |
|
| |
Giovanni Targher †, University of Verona
Whole-Patient Cardiovascular and Extra-hepatic Cancers in MASH |
|
| |
Katherine R. Tuttle †, University of Washington
The Kidney in CKLM |
|
| |
Luca Lotta †, Regeneron Pharmaceuticals Inc.
Human Genetics to Identify Shared Targets Across MASH and Cardiovascular-Kidney-Metabolic Disease |
|
| |
Short Talk(s) Chosen from Abstracts
|
|
| 9:30–9:50 AM |
Coffee Break |
|
| 11:25–12:25 PM |
Meet-the-Editor |
|
| 12:25–5:00 PM |
On Own for Lunch |
|
| 1:00–10:00 PM |
Poster Viewing |
|
| 2:30–4:30 PM |
Symposia Spotlight 1 |
|
| |
Short Talks Chosen from Abstracts
|
|
| 4:30–5:00 PM |
Coffee Available |
|
| 5:00–7:00 PM |
Mechanisms of Inter-Organ Crosstalk in MASH and CKLM |
|
| |
Jia-Horng Kao, National Taiwan University
Infection Interaction with MASLD and CKLM Outcomes in Viral Hepatitis |
|
| |
Neil C. Henderson †, Institute of Regeneration and Repair, University of Edinburgh
Shared Fibrotic Programs Across the Liver, Heart and Kidney in MASH |
|
| |
Yonglun Luo †, Aarhus University
Endothelial Dysfunction as an Inter-Organ Mechanism in MASH and CKLM |
|
| |
Florian Kahles †, University Hospital RWTH Aachen
Inflammation as a Unifying Mechanism in MASH and CKLM |
|
| |
Short Talk(s) Chosen from Abstracts
|
|
| 7:00–8:00 PM |
Social Hour with Dinner |
|
| 8:00–11:00 AM |
Metabolic and Cardio-Renal-Liver Axes in MASH |
|
| |
Lale Ozcan †, Columbia University
The Liver in the Inter-Organ Cross-Talk from Pre-Diabetes to Diabetes |
|
| |
Kai-Chien Yang, National Taiwan University
Liver Cross-Talk with the Cardiovascular System |
|
| |
Katalin Susztak †, University of Pennsylvania
Liver-Kidney Cross-Talk in CKLM |
|
| |
Short Talk(s) Chosen from Abstracts
|
|
| 9:00–9:20 AM |
Coffee Break |
|
| 11:00–1:00 PM |
Poster Setup |
|
| 11:00–5:00 PM |
On Own for Lunch |
|
| 1:00–10:00 PM |
Poster Viewing |
|
| 3:00–4:30 PM |
Career Roundtable |
|
| 4:30–5:00 PM |
Coffee Available |
|
| 5:00–7:00 PM |
Gut-Liver-Adipose Signaling in MASH and CKLM |
|
| |
Susanne Mandrup †, University of Southern Denmark
Liver-Adipose Tissue Cross-Talk Mechanisms |
|
| |
Rebecca A Haeusler †, Columbia University
Liver-Intestine Communication in CKLM |
|
| |
Harry Sokol †, Saint-Antoine Hospital
Gut Microbiota and Hepatic Inflammation in CKLM |
|
| |
Takahiro Ochiya †, Tokyo Medical University
Hepatic Exosomes in CKLM |
|
| |
Short Talk(s) Chosen from Abstracts
|
|
| 7:00–8:00 PM |
Social Hour with Dinner |
|
| 8:00–11:00 AM |
Human-Relevant Models, Multi-Omics, and AI for MASH Across Organ Systems |
|
| |
Vincent WS Wong †, Chinese University of Hong Kong
Non-Invasive Tests to Assess Liver Dysfunction and Multi-Organ Failure in CKLM |
|
| |
Joseph C. Wu †, Stanford University
Organoids / Organ-on-Chip: in vitro Modeling of Liver-Heart-Kidney Crosstalk |
|
| |
Karin Conde-Knape †, Valo Health
AI to Accelerate Drug Development Acting on Multi-Organs in CKLM |
|
| |
Bart Staels, Institut Pasteur de Lille, Université Lille
Experimental Models of Obesity, Metabolic Liver and Cardiovascular Disease |
|
| |
Short Talk(s) Chosen from Abstracts
|
|
| 9:00–9:20 AM |
Coffee Break |
|
| 11:00–5:00 PM |
On Own for Lunch |
|
| 2:30–4:30 PM |
Symposia Spotlight 2 |
|
| |
Short Talks Chosen from Abstracts
|
|
| 4:30–5:00 PM |
Coffee Available |
|
| 5:00–6:45 PM |
Therapeutic Translation to Address Multi-Organ Disease in MASH and CKLM |
|
| |
Ruth E. Gimeno †, Eli Lilly and Company
Role of Incretins in CKLM |
|
| |
Timothy P Rolph †, Akero Therapeutics
FGF21 in CKLM |
|
| |
Rebecca A. Taub †, Madrigal Pharmaceuticals
Targeting Thyroid Hormone Receptors in MASH with Impact on CKM |
|
| |
Lakshmi Santhanam †, Johns Hopkins University
Tissue-Selective Drug Delivery |
|
| |
Short Talk(s) Chosen from Abstracts
|
|
| 6:45–7:00 PM |
Meeting Wrap-Up: Outcomes and Future Directions |
|
| 7:00–8:00 PM |
Social Hour with Dinner |
|
| 8:00–11:00 PM |
Entertainment |
|
Wednesday, January 5, 2028
